|
DE69940958D1
(de)
|
1998-12-23 |
2009-07-16 |
Glaxo Group Ltd |
Bestimmungsmethode fur liganden der nuklearen rezeptoren
|
|
IL146732A0
(en)
*
|
1999-06-03 |
2002-07-25 |
Nippon Suisan Kaisha Ltd |
Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
|
|
ATE381542T1
(de)
|
2001-08-13 |
2008-01-15 |
Phenex Pharmaceuticals Ag |
Nr1h4-kern-rezeptor-bindende verbindungen
|
|
CN1681388A
(zh)
*
|
2002-09-18 |
2005-10-12 |
Fmc有限公司 |
三环衍生物杀虫剂
|
|
WO2004048349A1
(en)
|
2002-11-22 |
2004-06-10 |
Smithkline Beecham Corporation |
Farnesoid x receptor agonists
|
|
WO2007076260A2
(en)
|
2005-12-19 |
2007-07-05 |
Smithkline Beecham Corporation |
Farnesoid x receptor agonists
|
|
CA2640476A1
(en)
|
2006-02-03 |
2007-08-16 |
Eli Lilly And Company |
Compounds and methods for modulating fx-receptors
|
|
JP2007230909A
(ja)
|
2006-03-01 |
2007-09-13 |
Univ Of Tokyo |
置換イソキサゾール誘導体
|
|
TW200812982A
(en)
|
2006-05-24 |
2008-03-16 |
Lilly Co Eli |
Compounds and methods for modulating FXR
|
|
CN101448791B
(zh)
*
|
2006-05-24 |
2011-11-16 |
伊莱利利公司 |
Fxr激动剂
|
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
|
EP1894928A1
(en)
|
2006-08-29 |
2008-03-05 |
PheneX Pharmaceuticals AG |
Heterocyclic fxr binding compounds
|
|
CL2007003035A1
(es)
|
2006-10-24 |
2008-05-16 |
Smithkline Beechman Corp |
Compuestos derivados de isoxazol sustituidos, agonistas de receptores farnesoid x; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso del compuesto en el tratamiento de la obesidad, diabetes mellitus, fibrosis en organos,
|
|
KR20100038102A
(ko)
|
2007-06-13 |
2010-04-12 |
글락소스미스클라인 엘엘씨 |
파네소이드 ｘ 수용체 작용제
|
|
MX2009013946A
(es)
|
2007-07-02 |
2010-03-10 |
Glaxosmithkline Llc |
Agonistas del receptor de farnesoide x.
|
|
TW200906823A
(en)
|
2007-07-16 |
2009-02-16 |
Lilly Co Eli |
Compounds and methods for modulating FXR
|
|
EP2128158A1
(en)
|
2008-05-26 |
2009-12-02 |
Phenex Pharmaceuticals AG |
Heterocyclic cyclopropyl-substituted FXR binding compounds
|
|
EP2289883A1
(en)
*
|
2009-08-19 |
2011-03-02 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
EP2655368A1
(en)
|
2010-12-20 |
2013-10-30 |
Irm Llc |
Compositions and methods for modulating farnesoid x receptors
|
|
WO2012087521A1
(en)
|
2010-12-20 |
2012-06-28 |
Irm Llc |
Compositions and methods for modulating farnesoid x receptors
|
|
CU24152B1
(es)
|
2010-12-20 |
2016-02-29 |
Irm Llc |
1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
DK3043865T3
(da)
|
2013-09-11 |
2021-02-01 |
Univ Claude Bernard Lyon |
Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
|
|
CN104513213A
(zh)
|
2013-09-28 |
2015-04-15 |
山东亨利医药科技有限责任公司 |
Fxr激动剂
|
|
BR112016009630B1
(pt)
*
|
2013-11-05 |
2021-02-09 |
Novartis Ag |
receptores de farnesoide x, seus usos, combinação e composição farmacêutica
|
|
CN104045635A
(zh)
|
2014-06-23 |
2014-09-17 |
华东理工大学 |
3,4,5-三取代异恶唑类化合物及其用途
|
|
EP3034499A1
(en)
|
2014-12-17 |
2016-06-22 |
Gilead Sciences, Inc. |
Novel FXR (NR1H4) modulating compounds
|
|
EP3034501A1
(en)
|
2014-12-17 |
2016-06-22 |
Gilead Sciences, Inc. |
Hydroxy containing FXR (NR1H4) modulating compounds
|
|
MX2017008057A
(es)
|
2014-12-18 |
2017-09-28 |
Novartis Ag |
Derivados de azabiciclooctano como agonistas de fxr para el uso en el tratamiento de enfermedades hepaticas y gastrointestinales.
|
|
CN107438612A
(zh)
*
|
2014-12-22 |
2017-12-05 |
阿卡纳治疗学有限公司 |
用于治疗疾病的稠合双环化合物
|
|
TWI698430B
(zh)
*
|
2015-02-13 |
2020-07-11 |
南北兄弟藥業投資有限公司 |
三環化合物及其在藥物中的應用
|
|
CN106146483A
(zh)
|
2015-04-23 |
2016-11-23 |
上海迪诺医药科技有限公司 |
杂环类法尼酯衍生物x受体调节剂
|
|
CN106946867B
(zh)
|
2016-01-06 |
2019-11-12 |
广州市恒诺康医药科技有限公司 |
Fxr受体调节剂及其制备方法和用途
|
|
WO2017128896A1
(zh)
|
2016-01-26 |
2017-08-03 |
江苏豪森药业集团有限公司 |
Fxr激动剂及其制备方法和应用
|
|
CN107021957A
(zh)
|
2016-02-01 |
2017-08-08 |
山东轩竹医药科技有限公司 |
Fxr受体激动剂
|
|
CN107021958A
(zh)
*
|
2016-02-01 |
2017-08-08 |
山东轩竹医药科技有限公司 |
Fxr受体激动剂
|
|
WO2017133521A1
(zh)
|
2016-02-01 |
2017-08-10 |
山东轩竹医药科技有限公司 |
Fxr受体激动剂
|
|
TW201741307A
(zh)
|
2016-02-22 |
2017-12-01 |
艾洛斯生物製藥公司 |
Ｆｘｒ調節劑及其使用方法
|
|
US10080741B2
(en)
|
2016-04-26 |
2018-09-25 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as FXR agonists and methods of use thereof
|
|
WO2017189651A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017189663A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017201152A1
(en)
|
2016-05-18 |
2017-11-23 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017201150A1
(en)
|
2016-05-18 |
2017-11-23 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as fxr agonists and methods of use thereof
|
|
WO2017201155A1
(en)
|
2016-05-18 |
2017-11-23 |
Enanta Pharmaceuticals, Inc. |
lSOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
|
|
AR108711A1
(es)
|
2016-06-13 |
2018-09-19 |
Gilead Sciences Inc |
Compuestos moduladores de fxr (nr1h4)
|
|
MX385718B
(es)
|
2016-06-13 |
2025-03-18 |
Gilead Sciences Inc |
Compuestos moduladores de fxr (nr1h4).
|
|
TW201808283A
(zh)
*
|
2016-08-05 |
2018-03-16 |
廣東東陽光藥業有限公司 |
含氮三環化合物及其在藥物中的應用
|
|
CN116854681A
(zh)
|
2016-08-23 |
2023-10-10 |
阿德利克斯股份有限公司 |
用于治疗代谢病状和病症的激素受体调节剂
|
|
WO2018039384A1
(en)
|
2016-08-23 |
2018-03-01 |
Ardelyx, Inc. |
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as fxr activators
|
|
CN108430998B
(zh)
|
2016-09-28 |
2021-07-09 |
四川科伦博泰生物医药股份有限公司 |
氮杂双环衍生物及其制备方法和用途
|
|
US10450306B2
(en)
|
2016-10-04 |
2019-10-22 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as FXR agonists and methods of use thereof
|
|
CN107973790A
(zh)
|
2016-10-22 |
2018-05-01 |
合帕吉恩治疗公司 |
杂环fxr调节剂
|
|
WO2018081285A1
(en)
|
2016-10-26 |
2018-05-03 |
Enanta Pharmaceuticals, Inc. |
Urea-containing isoxazole derivatives as fxr agonists and methods of use thereof
|
|
CN108017636A
(zh)
|
2016-11-04 |
2018-05-11 |
合帕吉恩治疗公司 |
作为fxr调节剂的含氮杂环化合物
|
|
CN108218852A
(zh)
|
2016-12-15 |
2018-06-29 |
宁波百纳西药业有限公司 |
一种螺环化合物、其制备方法、组合物及用途
|
|
CN106632294A
(zh)
|
2016-12-15 |
2017-05-10 |
宁波百纳西药业有限公司 |
一种螺环化合物及其药物用途
|
|
WO2018133730A1
(zh)
|
2017-01-20 |
2018-07-26 |
四川科伦博泰生物医药股份有限公司 |
一种杂环化合物及其制备方法和用途
|
|
CN108341822B
(zh)
|
2017-01-23 |
2021-04-16 |
广州市恒诺康医药科技有限公司 |
Fxr受体调节剂及其制备方法和应用
|
|
PL3612520T3
(pl)
|
2017-04-12 |
2022-03-21 |
Il Dong Pharmaceutical Co., Ltd. |
Pochodne izoksazolu jako agoniści receptora jądrowego i ich zastosowania
|
|
EP3632910B1
(en)
|
2017-05-26 |
2024-07-17 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
3,4-dihydroquinolinones as fxr receptor agonists
|
|
KR102400183B1
(ko)
|
2017-07-06 |
2022-05-18 |
수안주 바이오파마슈티컬 컴퍼니 리미티드 |
Fxr 작용제
|
|
CN109320509B
(zh)
|
2017-07-31 |
2022-02-08 |
轩竹生物科技股份有限公司 |
Fxr受体激动剂
|
|
CN109320517B
(zh)
|
2017-07-31 |
2021-08-17 |
轩竹生物科技有限公司 |
Fxr受体激动剂
|
|
EP3681881B1
(en)
|
2017-09-14 |
2022-11-02 |
Ardelyx, Inc. |
Hormone receptor modulators for treating metabolic mutagenic and fibrotic conditions and disorders
|
|
CN111278817B
(zh)
|
2017-11-01 |
2023-05-16 |
百时美施贵宝公司 |
作为法尼醇x受体调节剂的多环化合物
|
|
CN111511731B
(zh)
|
2017-11-01 |
2023-05-23 |
百时美施贵宝公司 |
作为法尼醇x受体调节剂的烯烃化合物
|
|
AU2018360575A1
(en)
|
2017-11-01 |
2020-06-18 |
Bristol-Myers Squibb Company |
Alkene spirocyclic compounds as farnesoid X receptor modulators
|
|
PE20201170A1
(es)
|
2017-11-01 |
2020-10-28 |
Bristol Myers Squibb Co |
Compuestos biciclicos en puente como moduladores del receptor farnesoide x
|
|
WO2019118571A1
(en)
|
2017-12-12 |
2019-06-20 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as fxr agonists and methods of use thereof
|
|
KR20200102415A
(ko)
|
2017-12-22 |
2020-08-31 |
쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 |
이소옥사졸 유도체, 그 제조 방법 및 그 용도
|
|
CN108264506B
(zh)
|
2018-01-17 |
2021-01-26 |
中国药科大学 |
异黄酮衍生物、其制备方法和医药用途
|